MBX Biosciences, Inc. (MBX) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
MBX currently has 46.6M outstanding shares. with significant dilution risk as 35.5M authorized shares could dilute existing holders by 76.3%. The company has significantly diluted shareholders by 51.48% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 07, 2026 |
10-Q filing | 46.6M shares outstanding |
47M | 36M |
| Mar 12, 2026 |
10-K filing | 47.5M shares outstanding |
48M | 36M |
| Nov 06, 2025 |
S-3 filing: The company may offer and sell up to $400,000,000 in aggregate principal amount of any combination of common stock, preferred stock, or debt securities. |
45M | 36M |
| Nov 06, 2025 |
10-Q filing | 44.9M shares outstanding |
45M | 28M |
| Sep 26, 2025 |
8-K filing: MBX Biosciences, Inc. completed a public offering of 11,108,055 shares of common stock at $18.00 per share, resulting in net proceeds of approximately $187.5 million. ($187.5M proceeds) |
33M | 28M |
| Sep 22, 2025 |
S-1 filing: The company is offering 10,000,000 shares of common stock in an S-1 filing. |
33M | 28M |
| May 12, 2025 |
10-Q filing | 33.4M shares outstanding |
33M | 18M |
| Mar 17, 2025 |
10-K filing | 33.4M shares outstanding |
33M | 18M |
| Nov 07, 2024 |
10-Q filing | 33.4M shares outstanding |
33M | 18M |
| Sep 09, 2024 |
S-1/A filing: This S-1/A filing relates to an offering of common stock, with underwriters having an option to purchase additional shares. The company intends to list its common stock on the Nasdaq Global Select Market under the symbol “MBX.” |
30M | 18M |
| Aug 30, 2024 |
S-1/A filing: S-1/A filing for common stock offering with J.P. Morgan, Jefferies, Stifel, and Guggenheim Securities as underwriters. |
260M | 0 |
| Aug 23, 2024 |
S-1 filing: This S-1 filing is for an initial public offering of common stock, with J.P. Morgan, Jefferies, Stifel, and Guggenheim Securities acting as underwriters. The company has applied to list its common stock on the Nasdaq Global Select Market under the symbol 'MBX'. |
260M | 0 |